SCHEMBL25949658

SCHEMBL25949658

CCc1c(C)cc(CC(=O)O)c(C)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.42
PTGS2 P35354 4/20 0.42
NPSR1 Q6W5P4 1/20 0.41
ALOX15 P16050 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
SRC P12931 1/20 0.38
RXRA P19793 2/20 0.36
RXRB P28702 2/20 0.36
RXRG P48443 1/20 0.36
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
AKR1B1 P15121 1/20 0.34
HSD17B10 Q99714 1/20 0.34
AGBL2 Q5U5Z8 1/20 0.34
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28350464 0.82 PGK1 (0.35) NPSR1ALOX15MAPTHSD17B10CYP1A2
SCHEMBL18685992 0.81 PTGS1 (0.45) PTGS1PTGS2NPSR1ALOX15SMN1; SMN2
SCHEMBL1259129 0.80 ALOX15 (0.49) PTGS1PTGS2NPSR1ALOX15SMN1; SMN2
SCHEMBL30990555 0.80 ALOX15 (0.49) PTGS1PTGS2NPSR1ALOX15SMN1; SMN2
Phosphine SCHEMBL28245494 0.79 ALOX15 (0.47) PTGS1PTGS2NPSR1ALOX15SMN1; SMN2
Ammonia Solution, Strong SCHEMBL28842319 0.79 ALOX15 (0.47) PTGS1PTGS2NPSR1ALOX15SMN1; SMN2
SCHEMBL16527228 0.78 ALOX15 (0.50) PTGS1PTGS2NPSR1ALOX15SMN1; SMN2
SCHEMBL11325941 0.75 NPSR1 (0.60) PTGS1PTGS2NPSR1ALOX15SMN1; SMN2
SCHEMBL25949767 0.75 THRB (0.44) HPGDTSHRPOLBMAPTKDM4E
SCHEMBL28347480 0.73 PGK1 (0.40) NPSR1ALOX15MAPTHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242471-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242471-A1 THYROMIMETICS TPO, THOP1, THRB PTGS1 367/4885PTGS2 1091/4885NPSR1 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.